Inerolysin, a cholesterol-dependent cytolysin produced by Lactobacillus iners∇

Journal of Bacteriology

Volumn 193, Issue 5, 2011, Pages 1034-1041

  Rampersaud, Ryan ^a   Planet, Paul J ^a   Randis, Tara M ^a   Kulkarni, Ritwij ^a   Aguilar, Jorge L ^a   Lehrer, Robert I ^b   Ratner, Adam J ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CHOLESTEROL; CYTOLYSIN; INEROLYSIN; INTERMEDILYSIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHALLOIDIN; UNCLASSIFIED DRUG; VAGINOLYSIN;

ACIDITY; ALKALINITY; AMINO ACID SEQUENCE; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CYTOPLASM; EPITHELIUM CELL; GARDNERELLA VAGINALIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LACTOBACILLUS; LACTOBACILLUS INERS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STREPTOCOCCUS INTERMEDIUS; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHOLESTEROL; CYTOTOXINS; GENE EXPRESSION REGULATION, BACTERIAL; LACTOBACILLUS; MUTATION; STRESS, PHYSIOLOGICAL; ULTRAVIOLET RAYS;

BACTERIA (MICROORGANISMS); GARDNERELLA VAGINALIS; LACTOBACILLUS; LACTOBACILLUS INERS; STREPTOCOCCUS INTERMEDIUS;

EID: 79951607127     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00694-10     Document Type: Article

References (43)

1. Aguilar, J. L., et al. 2009. Phosphatase-dependent regulation of epithelial mitogen-activated protein kinase responses to toxin-induced membrane pores. PLoS One 4:e8076.
2. Bendtsen, J. D., H. Nielsen, G. von Heijne, and S. Brunak. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340:783-795.
3. Billington, S. J., B. H. Jost, W. A. Cuevas, K. R. Bright, and J. G. Songer. 1997. The Arcanobacterium (Actinomyces) pyogenes hemolysin, pyolysin, is a novel member of the thiol-activated cytolysin family. J. Bacteriol. 179:6100-6106.
4. Billington, S. J., J. G. Songer, and B. H. Jost. 2001. Molecular characterization of the pore-forming toxin, pyolysin, a major virulence determinant of Arcanobacterium pyogenes. Vet. Microbiol. 82:261-274.
5. Cauci, S. 2004. Vaginal immunity in bacterial vaginosis. Curr. Infect. Dis. Rep. 6:450-456.
6. Cauci, S., S. Driussi, S. Guaschino, M. Isola, and F. Quadrifoglio. 2002. Correlation of local interleukin-1beta levels with specific IgA response against Gardnerella vaginalis cytolysin in women with bacterial vaginosis. Am. J. Reprod. Immunol. 47:257-264.
7. De Backer, E., et al. 2007. Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiol. 7:115.
8. Donati, L., et al. 2010. Vaginal microbial flora and outcome of pregnancy. Arch. Gynecol. Obstet. 281:589-600.
9. Falsen, E., C. Pascual, B. Sjoden, M. Ohlen, and M. D. Collins. 1999. Phenotypic and phylogenetic characterization of a novel Lactobacillus species from human sources: description of Lactobacillus iners sp. nov. Int. J. Syst. Bacteriol. 49(Pt. 1):217-221.
10. Farrand, A. J., S. LaChapelle, E. M. Hotze, A. E. Johnson, and R. K. Tweten. 2010. Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc. Natl. Acad. Sci. U. S. A. 107: 4341-4346.
11. Ferris, M. J., J. Norori, M. Zozaya-Hinchliffe, and D. H. Martin. 2007. Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J. Clin. Microbiol. 45:1016-1018.
12. Gelber, S. E., J. L. Aguilar, K. L. Lewis, and A. J. Ratner. 2008. Functional and phylogenetic characterization of vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. J. Bacteriol. 190:3896-3903.
13. Geoffroy, C., J. L. Gaillard, J. E. Alouf, and P. Berche. 1987. Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect. Immun. 55:1641-1646. (Pubitemid 17084156)
14. Giddings, K. S., J. Zhao, P. J. Sims, and R. K. Tweten. 2004. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat. Struct. Mol. Biol. 11:1173-1178.
15. Glomski, I. J., M. M. Gedde, A. W. Tsang, J. A. Swanson, and D. A. Portnoy. 2002. The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells. J. Cell Biol. 156:1029-1038.
16. Hughes, T. R., et al. 2009. Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59. Mol. Immunol. 46:1561-1567.
17. Lehrer, R. I., et al. 2009. Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins. Infect. Immun. 77:4028-4040.
18. Madden, J. C., N. Ruiz, and M. Caparon. 2001. Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in gram-positive bacteria. Cell 104:143-152. (Pubitemid 32144979)
19. Nagamune, H., et al. 1996. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect. Immun. 64:3093-3100.
20. Palmer, M. 2001. The family of thiol-activated, cholesterol-binding cytolysins. Toxicon 39:1681-1689. (Pubitemid 32787000)
21. Polekhina, G., K. S. Giddings, R. K. Tweten, and M. W. Parker. 2005. Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin. Proc. Natl. Acad. Sci. U. S. A. 102:600-605.
22. Ramachandran, R., A. P. Heuck, R. K. Tweten, and A. E. Johnson. 2002. Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Nat. Struct. Biol. 9:823-827.
23. Ramachandran, R., R. K. Tweten, and A. E. Johnson. 2004. Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit beta-strand alignment. Nat. Struct. Mol. Biol. 11:697-705.
24. Ramachandran, R., R. K. Tweten, and A. E. Johnson. 2005. The domains of a cholesterol-dependent cytolysin undergo a major FRET-detected rear-rangement during pore formation. Proc. Natl. Acad. Sci. U. S. A. 102:7139-7144.
25. Randis, T. M., R. Kulkarni, J. L. Aguilar, and A. J. Ratner. 2009. Antibody-based detection and inhibition of vaginolysin, the Gardnerella vaginalis cytolysin. PLoS One 4:e5207.
26. Ratner, A. J., J. L. Aguilar, M. Shchepetov, E. S. Lysenko, and J. N. Weiser. 2007. Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria. Cell. Microbiol. 9:1343-1351.
27. Ratner, A. J., et al. 2006. Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J. Biol. Chem. 281:12994-12998.
28. Ratner, A. J., E. S. Lysenko, M. N. Paul, and J. N. Weiser. 2005. Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc. Natl. Acad. Sci. U. S. A. 102:3429-3434.
29. Ravel, J., et al. 3 June 2010, posting date. Microbes and Health Sackler Colloquium: vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U. S. A. doi:10.1073/pnas.1002611107.
30. Rosado, C. J., et al. 2008. The MACPF/CDC family of pore-forming toxins. Cell. Microbiol. 10:1765-1774.
31. Schuerch, D. W., E. M. Wilson-Kubalek, and R. K. Tweten. 2005. Molecular basis of listeriolysin O pH dependence. Proc. Natl. Acad. Sci. U. S. A. 102:12537-12542.
32. Shannon, J. G., C. L. Ross, T. M. Koehler, and R. F. Rest. 2003. Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin. Infect. Immun. 71:3183-3189.
33. Shi, Y., L. Chen, J. Tong, and C. Xu. 2009. Preliminary characterization of vaginal microbiota in healthy Chinese women using cultivation-independent methods. J. Obstet. Gynaecol. Res. 35:525-532.
34. Soltani, C. E., E. M. Hotze, A. E. Johnson, and R. K. Tweten. 2007. Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions. Proc. Natl. Acad. Sci. U. S. A. 104:20226-20231.
35. Srinivasan, S., and D. N. Fredricks. 2008. The human vaginal bacterial biota and bacterial vaginosis. Interdiscip. Perspect. Infect. Dis. 2008:750479.
36. Srinivasan, S., et al. 2010. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One 5:e10197.
37. Swofford, D. L. 1998. PAUP: phylogenetic analysis using parsimony (*and other methods) 4.0 beta. Sinauer Associates, Sunderland, MA.
38. Tweten, R. K. 2005. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun. 73:6199-6209.
39. Valore, E. V., D. J. Wiley, and T. Ganz. 2006. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect. Immun. 74:5693-5702.
40. Verstraelen, H., et al. 2009. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol. 9:116.
41. Wilks, M., et al. 2004. Identification and H(2)O(2) production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J. Clin. Microbiol. 42:713-717.
42. Zhou, X., et al. 2004. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 150:2565-2573. (Pubitemid 39173262)
43. Zozaya-Hinchliffe, M., R. Lillis, D. H. Martin, and M. J. Ferris. 2010. Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J. Clin. Microbiol. 48:1812-1819.